Bruce Goldsmith's most recent trade in Passage Bio Inc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 27, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Passage Bio Inc | Bruce Goldsmith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Passage Bio Inc | Bruce Goldsmith | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 21 Mar 2022 | 10,000 | 15,983 (0%) | 0% | 3.2 | 31,500 | Common Stock |
| Passage Bio Inc | Bruce Goldsmith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Passage Bio Inc | Bruce Goldsmith | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 13.12 per share. | 21 May 2021 | 2,000 | 5,983 (0%) | 0% | 13.1 | 26,230 | Common Stock |
| Passage Bio Inc | Bruce Goldsmith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 262,000 | 262,000 | - | - | Stock Option (right to buy) |